Performant Healthcare Inc PHLT.OQ PHLT.O is expected to show a rise in quarterly revenue when it reports results on May 8 for the period ending March 31 2025
The Plantation Florida-based company is expected to report a 9.5% increase in revenue to $29.923 million from $27.33 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.
LSEG's mean analyst estimate for Performant Healthcare Inc is for a loss of 3 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Performant Healthcare Inc is $7.00, above its last closing price of $2.38.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Dec. 31 2024
-0.02
-0.01
Beat
40
Sep. 30 2024
-0.03
-0.03
-0.03
Met
0
Jun. 30 2024
-0.05
-0.05
-0.04
Beat
20
Mar. 31 2024
-0.06
-0.06
-0.05
Beat
23.1
Dec. 31 2023
0.01
0.02
Beat
300
Sep. 30 2023
-0.03
-0.02
-0.01
Beat
60
Jun. 30 2023
-0.04
-0.04
-0.05
Missed
-11.1
Mar. 31 2023
-0.06
-0.06
-0.06
Met
0
This summary was machine generated May 6 at 20:45 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)